🇺🇸 SECEyePoint Inc.Codex · 实盘不做把握 5/10
北京时间·🕒 发布 19:05:22时区推断·⟳ 抓取 19:06:24·⚡ 决策 08-05 21:49:58 +2h43m·82.8 天前
EyePoint发布二季度财报8-K及更新投资者演示材料
当前信号正文只披露EyePoint提交8-K、发布二季度财务结果新闻稿和投资者材料,未给出收入、EPS、现金 runway 或临床里程碑的新增超预期数据。
📄 原文EyePoint Inc.↗ 原文
false 0001314102 0001314102 2026-08-05 2026-08-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 205…
不做 EyePoint, Inc.(EYPT.US)
仅看到8-K封面确认发布财报和投资者材料,缺少实际业绩、现金runway或DURAVYU临床进展的超预期增量;财报日期已在日历中,当前不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
消息传播链
- EyePoint提交8-K,说明公司发布截至2026-06-30季度财务结果新闻稿并同步更新投资者演示材料;正文未披露具体业绩数值或临床新增事实。
关键理由
- 当前信号正文只披露EyePoint提交8-K、发布二季度财务结果新闻稿和投资者材料,未给出收入、EPS、现金 runway 或临床里程碑的新增超预期数据。
- 小型临床阶段生物科技公司的季度财报交易核心通常是现金 runway、融资风险或临床进度变化;本条可见信息只是预定财报披露本身,无法形成方向一致的短线edge。
主要风险
- 若Exhibit 99.1/99.2中实际包含DURAVYU三期读出时间提前、现金 runway 明显变化或融资计划等新增事实,应由新信号重新研判。
原文全文
展开原文 · 3,125 字
false
0001314102
0001314102
2026-08-05
2026-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 05, 2026
EyePoint, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
000-51122
26-2774444
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
480 Pleasant Street
Watertown
,
Massachusetts
02472
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code:
(617)
926-5000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001
EYPT
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02 Results of Operations and Financial Condition.
On August 5, 2026, EyePoint, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026 and certain other information. A copy of the press release is furnished as Exhibit 99.1 hereto.
Also on August 5, 2026, the Company posted an updated investor presentation on its website at www.eyepoint.bio. A copy of the presentation is filed herewith as Exhibit 99.2 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of EyePoint, Inc., dated August 5, 2026
99.2
Investor Presentation of EyePoint, Inc., dated August 5, 2026
104
Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EYEPOINT, INC.
Date:
August 5, 2026
By:
/s/ George O. Elston
George O. Elston
Executive Vice President and Chief Financial Officer
0001314102
0001314102
2026-08-05
2026-08-05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 05, 2026
EyePoint, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware
000-51122
26-2774444
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
480 Pleasant Street
Watertown
,
Massachusetts
02472
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code:
(617)
926-5000
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001
EYPT
The Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 2.02 Results of Operations and Financial Condition.
On August 5, 2026, EyePoint, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2026 and certain other information. A copy of the press release is furnished as Exhibit 99.1 hereto.
Also on August 5, 2026, the Company posted an updated investor presentation on its website at www.eyepoint.bio. A copy of the presentation is filed herewith as Exhibit 99.2 and is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99.1
Press Release of EyePoint, Inc., dated August 5, 2026
99.2
Investor Presentation of EyePoint, Inc., dated August 5, 2026
104
Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EYEPOINT, INC.
Date:
August 5, 2026
By:
/s/ George O. Elston
George O. Elston
Executive Vice President and Chief Financial Officer
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。